Bharat Biotech Covid-19 vaccine | The Business Standard
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Wednesday
August 17, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
WEDNESDAY, AUGUST 17, 2022

Bharat Biotech Covid-19 vaccine

FILE PHOTO: Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
Coronavirus chronicle

India gives nod to Bharat Biotech for intranasal Covid booster doses

The trials will be held at nice different sites

WHO issues emergency use listing for COVAXIN Covid-19 jab
Coronavirus chronicle

WHO issues emergency use listing for COVAXIN Covid-19 jab

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
Coronavirus chronicle

India recommends homemade Covid-19 vaccine for kids aged 2 and above

The Covid-19 active cases in the country have further declined to 4,59,920 and constitute 1.52 per cent of the caseload. Photo :AFP via Hindustan Times
Coronavirus chronicle

India to miss end-July vaccination target as Bharat Biotech lags

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called Covaxin, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
Coronavirus chronicle

India's Bharat Biotech says regulatory steps taken for Brazil vaccine contract

FILE PHOTO: Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
Coronavirus chronicle

Brazil official warned Bolsonaro over pressure to buy Bharat vaccine

Covaxin is produced by Bharat Biotech and is one of the vaccines being used in the nationwide inoculation drive. Photo :AFP via Hindustan Times
Coronavirus chronicle

Covaxin 77.8% effective in phase 3 trial data

FILE PHOTO: Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
Coronavirus chronicle

FDA rejects emergency use authorization of Bharat Biotech’s Covaxin jab

Photo: UNB
Coronavirus chronicle

Covaxin’s US approval delayed over data, Bharat Biotech’s partner to file for full approval

Photo: UNB
Coronavirus chronicle

Bharat Biotech submits ‘90% of documents’ for WHO nod

Bharat Biotech reduces Covaxin's price from Rs600 to Rs400 per dose for Indian states
Coronavirus chronicle

Bharat Biotech reduces Covaxin's price from Rs600 to Rs400 per dose for Indian states

Addressing a petroleum university’s convocation, Modi said: “Work is being done to nearly double the country’s oil refining capacity in the next five years” Photo: Collected from Twitter
Coronavirus chronicle

Narendra Modi gets second dose of Covid vaccine

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called Covaxin, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
Coronavirus chronicle

India's drug regulator panel eases use condition for home-grown vaccine

  • Show More
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]